心房細動手術市場：製品、適応症、エンドユーザー別-2025-2030年の世界予測

心房細動手術市場は、2023年に26億7,000万米ドルと評価され、2024年には29億米ドルに達すると予測され、CAGR 9.00%で成長し、2030年には48億8,000万米ドルに達すると予測されています。

心房細動（AF）手術は、心房細動に伴う不規則な心拍を修正するための医療処置であり、侵襲性の低い治療が失敗した場合に行われることが多いです。心房細動は脳卒中や心不全のような重篤な合併症を引き起こす可能性があるため、カテーテルアブレーションやメイズ手術などのこれらの手術は極めて重要です。その適用範囲は、症状のある患者と合併症のリスクが高い患者の両方に及び、病院や心臓専門センターによって促進されます。心房細動手術の世界市場は、主に高齢化による心房細動の有病率の上昇と、患者やヘルスケアプロバイダーの意識の高まりの影響を受けています。ロボット支援手術や改良されたカテーテルデザインのような技術革新は、治療成績の向上や回復時間の短縮につながる可能性を秘めています。しかし、こうした手技のコストが高く、未発達地域ではアクセスが限られていることが、市場拡大の足かせとなっています。規制状況や熟練した専門家の必要性が、状況をさらに複雑にしています。こうしたハードルを克服するためには、技術共有やトレーニングのための戦略的パートナーシップや協力関係がカギとなる可能性があります。研究・技術革新の面では、AIを活用した診断ツールや手術計画ツール、術後のモニタリングシステムの改善といった分野が有望な成長の道を示しています。さらに、保険適用と償還の枠組みの強化が市場開拓を加速させる可能性があります。同市場は急速な技術進歩を特徴とするが、規制機関からの監視にも直面しており、コンプライアンスと強固な臨床検証の必要性が強調されています。企業は、市場シェアを獲得するために、費用対効果の高いソリューションと患者転帰の改善を含む価値提案に注力しなければならないです。全体として、研究開発への戦略的投資と、患者アクセスの拡大や手続きコストの合理化への取り組みが、心房細動手術市場の持続的成長には不可欠です。

市場力学：急速に進化する心房細動手術市場の主要市場インサイトを公開

心房細動手術市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 老年人口における心房細動の有病率の上昇
  • 不整脈治療におけるカテーテルアブレーション嗜好の開発
  • 国民の意識を高めるための心房細動プログラムの増加
• 市場抑制要因
  • デバイスに関連する規制上の問題
• 市場機会
  • 低侵襲手術、心臓切開の縮小、術後の回復時間の短縮に対するニーズの高まり
  • 心房細動のカテーテルアブレーション技術の進歩
• 市場の課題
  • 熟練した専門家の不足と手術に対する人々の認識

ポーターのファイブフォース：心房細動手術市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：心房細動手術市場における外部からの影響の把握

外部マクロ環境要因は、心房細動手術市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析心房細動手術市場における競合情勢の把握

心房細動手術市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス心房細動手術市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、心房細動手術市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨心房細動手術市場における成功への道筋を描く

心房細動手術市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 高齢者における心房細動の有病率の上昇
    • 不整脈治療におけるカテーテルアブレーションの優先開発
    • 国民の意識を高めるAFプログラムの増加
  • 抑制要因
    • デバイスに関連する規制上の問題
  • 機会
    • 低侵襲手術、心臓切開の縮小、術後回復時間の短縮に対するニーズが高まっている
    • 心房細動のカテーテルアブレーションの技術的進歩
  • 課題
    • 熟練した専門家の不足と手術に関する人々の認識の欠如
• 市場セグメンテーション分析
  • 製品：カテーテルベースの処置の利用の増加に伴い、低侵襲処置の需要が高まっています。
  • 適応症：心房細動の優先治療としての迷路手術の出現
  • エンドユーザー：心臓病学および多専門科センターで実施される心房細動手術の迅速化
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 心房細動手術市場：製品別

• 心臓凍結アブレーションカテーテル
• 心臓マッピングシステム

第7章 心房細動手術市場適応症別

• 心房細動（AFib）
• 心房粗動
• 上室性頻拍（SVT）

第8章 心房細動手術市場：エンドユーザー別

• 心臓病学
• マルチスペシャリティ

第9章 南北アメリカの心房細動手術市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の心房細動手術市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの心房細動手術市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • GEヘルスケア、心房細動向けのCardioVisioを発表。これは、精密なケアを可能にするデジタルの患者中心の臨床意思決定支援ツールです。
  • バイオセンス・ウェブスター、透視なしでワークフローで使用できる複数の心房細動アブレーション製品のFDA承認を取得
  • メドトロニック、心房性不整脈治療用アフェラマッピングおよびアブレーションシステムのCEマーク承認を取得
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Acesion Pharma ApS
• Acutus Medical, Inc
• Affera, Inc.
• AFreeze GmbH
• Atrian Medical Ltd.
• AtriCure, Inc.
• AuriGen Medical
• BIOTRONIK SE & CO. KG
• Boston Scientific Corporation
• Cardiofocus, Inc.
• CathRx Ltd
• Cook Group Incorporated
• F. Hoffmann-La Roche AG
• GE HealthCare Technologies Inc.
• Healium Medical
• Japan Lifeline Co.
• Johnson & Johnson Services, Inc.
• Kardium Inc.
• Koninklijke Philips N.V.
• Medtronic PLC
• OMEICOS Therapeutics GmbH
• Osypka AG
• SentiAR, Inc
• Siemens Healthcare GmbH
• Stryker Corporation
• Terumo Corporation
• Thryv Therapeutics Inc.
• Toray Medical Co., Ltd.
• Vanguard AG
• Volta Medical

LIST OF FIGURES

• FIGURE 1. ATRIAL FIBRILLATION SURGERY MARKET RESEARCH PROCESS
• FIGURE 2. ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ATRIAL FIBRILLATION SURGERY MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. ATRIAL FIBRILLATION SURGERY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ATRIAL FIBRILLATION SURGERY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ATRIAL FIBRILLATION SURGERY MARKET DYNAMICS
• TABLE 7. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY CARDIAC CRYOABLATION CATHETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY CARDIAC MAPPING SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ATRIAL FIBRILLATION (AFIB), BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ATRIAL FLUTTER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SUPRAVENTRICULAR TACHYCARDIA (SVT), BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY MULTI SPECIALITIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 29. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 41. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 46. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 49. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. INDONESIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. MALAYSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. PHILIPPINES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. SINGAPORE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. TAIWAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. THAILAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. VIETNAM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 81. DENMARK ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. EGYPT ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. FINLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. ISRAEL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 101. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. NETHERLANDS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. NIGERIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. NORWAY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. POLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. POLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 113. POLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. QATAR ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 115. QATAR ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 116. QATAR ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. SAUDI ARABIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. SWEDEN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. SWITZERLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. TURKEY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. UNITED ARAB EMIRATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. ATRIAL FIBRILLATION SURGERY MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 145. ATRIAL FIBRILLATION SURGERY MARKET, FPNV POSITIONING MATRIX, 2023

The Atrial Fibrillation Surgery Market was valued at USD 2.67 billion in 2023, expected to reach USD 2.90 billion in 2024, and is projected to grow at a CAGR of 9.00%, to USD 4.88 billion by 2030.

Atrial fibrillation (AF) surgery involves medical procedures designed to correct the irregular heartbeat associated with AF, often pursued when less invasive treatments fail. These surgeries, such as catheter ablation or the Maze procedure, are vital as AF can lead to serious complications like stroke or heart failure. The application extends to both symptomatic individuals and those at significant risk of complications, facilitated by hospitals and specialized cardiac centers. The global market for AF surgeries is primarily influenced by the rising prevalence of AF due to an aging population and increased awareness among patients and healthcare providers. Technological advancements in surgical procedures and equipment are opening new opportunities, with innovations like robotic-assisted surgeries and improved catheter designs holding potential to enhance outcomes and reduce recovery times. However, the high cost of these procedures and limited access in underdeveloped regions constrain market expansion. Regulatory challenges and the need for skilled professionals further complicate the landscape. To overcome these hurdles, strategic partnerships and collaborations for technology sharing and training could be key. In terms of research and innovation, areas such as AI-driven diagnostic and surgical planning tools, as well as improved monitoring systems post-surgery, present promising avenues for growth. Furthermore, enhancing insurance coverage and reimbursement frameworks may accelerate market development. The market is characterized by rapid technological advancements but also faces scrutiny from regulatory bodies, emphasizing the need for compliance and robust clinical validation. Companies must focus on value propositions that include cost-effective solutions and improved patient outcomes to capture market share. Overall, strategic investments in R&D, combined with efforts to broaden patient access and streamline procedural costs, are critical for sustained growth in the atrial fibrillation surgery market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Atrial Fibrillation Surgery Market

The Atrial Fibrillation Surgery Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rise in prevalence of atrial fibrillation in geriatric population
  • Development in preference of catheter ablation for cardiac arrhythmia treatment
  • Growing number of AF programs to enhance public awareness
• Market Restraints
  • Regulatory issues associated with the devices
• Market Opportunities
  • Increasing need for minimally invasive procedures, smaller cardiac incisions, and faster post-surgical recovery times
  • Technological advances for catheter ablation of atrial fibrillation
• Market Challenges
  • Lack of skilled professionals and awareness among the people about the surgery

Porter's Five Forces: A Strategic Tool for Navigating the Atrial Fibrillation Surgery Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Atrial Fibrillation Surgery Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Atrial Fibrillation Surgery Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Atrial Fibrillation Surgery Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Atrial Fibrillation Surgery Market

A detailed market share analysis in the Atrial Fibrillation Surgery Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Atrial Fibrillation Surgery Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Atrial Fibrillation Surgery Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Atrial Fibrillation Surgery Market

A strategic analysis of the Atrial Fibrillation Surgery Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Atrial Fibrillation Surgery Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acesion Pharma ApS, Acutus Medical, Inc, Affera, Inc., AFreeze GmbH, Atrian Medical Ltd., AtriCure, Inc., AuriGen Medical, BIOTRONIK SE & CO. KG, Boston Scientific Corporation, Cardiofocus, Inc., CathRx Ltd, Cook Group Incorporated, F. Hoffmann-La Roche AG, GE HealthCare Technologies Inc., Healium Medical, Japan Lifeline Co., Johnson & Johnson Services, Inc., Kardium Inc., Koninklijke Philips N.V., Medtronic PLC, OMEICOS Therapeutics GmbH, Osypka AG, SentiAR, Inc, Siemens Healthcare GmbH, Stryker Corporation, Terumo Corporation, Thryv Therapeutics Inc., Toray Medical Co., Ltd., Vanguard AG, and Volta Medical.

Market Segmentation & Coverage

This research report categorizes the Atrial Fibrillation Surgery Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Cardiac Cryoablation Catheters and Cardiac Mapping System.
• Based on Indication, market is studied across Atrial Fibrillation (AFib), Atrial Flutter, and Supraventricular Tachycardia (SVT).
• Based on End-User, market is studied across Cardiology and Multi Specialities.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rise in prevalence of atrial fibrillation in geriatric population
    • 5.1.1.2. Development in preference of catheter ablation for cardiac arrhythmia treatment
    • 5.1.1.3. Growing number of AF programs to enhance public awareness
  • 5.1.2. Restraints
    • 5.1.2.1. Regulatory issues associated with the devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing need for minimally invasive procedures, smaller cardiac incisions, and faster post-surgical recovery times
    • 5.1.3.2. Technological advances for catheter ablation of atrial fibrillation
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of skilled professionals and awareness among the people about the surgery
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Minimally invasive procedures are on demand with the rising utilization of catheter-based procedures
  • 5.2.2. Indication: Emergence of maze procedure as a preferred treatment for atrial fibrillation
  • 5.2.3. End-User: Accelerating cases of atrial fibrillation surgeries conducted in cardiology and multi-specialty centers
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Atrial Fibrillation Surgery Market, by Product

• 6.1. Introduction
• 6.2. Cardiac Cryoablation Catheters
• 6.3. Cardiac Mapping System

7. Atrial Fibrillation Surgery Market, by Indication

• 7.1. Introduction
• 7.2. Atrial Fibrillation (AFib)
• 7.3. Atrial Flutter
• 7.4. Supraventricular Tachycardia (SVT)

8. Atrial Fibrillation Surgery Market, by End-User

• 8.1. Introduction
• 8.2. Cardiology
• 8.3. Multi Specialities

9. Americas Atrial Fibrillation Surgery Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Atrial Fibrillation Surgery Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Atrial Fibrillation Surgery Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. GE HealthCare Launches CardioVisio for Atrial Fibrillation, a Digital, Patient-Centric Clinical Decision Support Tool to Enable Precision Care
  • 12.3.2. Biosense Webster Receives FDA Approval for Multiple Atrial Fibrillation Ablation Products to be Used in a Workflow Without Fluoroscopy
  • 12.3.3. Medtronic Receives CE Mark Approval For Affera Mapping And Ablation System To Treat Atrial Arrhythmias
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Acesion Pharma ApS
• 3. Acutus Medical, Inc
• 4. Affera, Inc.
• 5. AFreeze GmbH
• 6. Atrian Medical Ltd.
• 7. AtriCure, Inc.
• 8. AuriGen Medical
• 9. BIOTRONIK SE & CO. KG
• 10. Boston Scientific Corporation
• 11. Cardiofocus, Inc.
• 12. CathRx Ltd
• 13. Cook Group Incorporated
• 14. F. Hoffmann-La Roche AG
• 15. GE HealthCare Technologies Inc.
• 16. Healium Medical
• 17. Japan Lifeline Co.
• 18. Johnson & Johnson Services, Inc.
• 19. Kardium Inc.
• 20. Koninklijke Philips N.V.
• 21. Medtronic PLC
• 22. OMEICOS Therapeutics GmbH
• 23. Osypka AG
• 24. SentiAR, Inc
• 25. Siemens Healthcare GmbH
• 26. Stryker Corporation
• 27. Terumo Corporation
• 28. Thryv Therapeutics Inc.
• 29. Toray Medical Co., Ltd.
• 30. Vanguard AG
• 31. Volta Medical